Try our beta test site

Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells

Expanded access is currently available for this treatment.
Verified August 2012 by Meir Medical Center
Sponsor:
Collaborator:
Tel Aviv University
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01267461
First received: December 27, 2010
Last updated: August 9, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Study Completion Date: No date given
  Primary Completion Date: No date given